Eslie Dennis, M.D.

Vice President of Scientific Affairs
Ventana Medical Systems

Dr. Eslie Dennis is a physician with 10 years’ experience in clinical practice (internal medicine and hematology/oncology), 1+ years’ laboratory research (immunology/tuberculosis), 16 years’ international experience in the biopharmaceutical industry, and 2+ years’ leadership experience in non-profit public-private partnerships.

She is Vice President of Scientific Affairs at Ventana Medical Systems, a member of the Roche Group. Ventana is focused on the development, manufacturing and commercialization of tissue-based cancer diagnostics. She provides leadership and oversight for all global scientific affairs activities.

Prior to joining Ventana, she was Executive Director of the Predictive Safety Testing Consortium and Executive Director for the Polycystic Kidney Disease Outcomes Consortium at the Critical Path Institute (C-Path),  where she created effective collaborations with global health authorities, the pharmaceutical industry, academia, the NIH, patient organizations, and other private sector and non-profit organizations. She was responsible for the development and execution of regulatory strategy and research plans to support the regulatory qualification of biomarkers, and led interactions with the U.S. Food and Drug Administration, the European Medicines Agency and the Japanese Pharmaceutical and Medical Devices Agency.

Prior to joining C-Path, she was Vice President and Medical Head Northeast for Novartis Pharmaceuticals Corporation, where she led a field-based medical affairs team and developed customer-focused and patient-focused medical strategies. She spent 14 years in the pharmaceutical industry overseeing pre-marketing development programs and leading post-marketing programs including Phase IIIb/IV, epidemiology and health economics and outcomes research, regulatory interactions and commercial experience. She has led Medical Affairs teams providing medical information services and medical input into strategic planning, training and medical education plans, and overseeing investigator initiated research studies. She also has significant experience with drug safety. In addition, she has led Medical Information/Communications, Publications and Education departments.

Dr. Dennis received her MBChB from the Godfrey Huggins School of Medicine in Harare, Zimbabwe, and was the recipient of the Winston Churchill, Margaret Low, and Prankard-Jones Scholarships, as well as the Guy Elliot Bursary.  She is a Fellow of the College of Physicians of South Africa and received her internal medicine and hematology/oncology training at Groote Schuur Hospital in Cape Town, South Africa.